User profiles for D Jullien

Denis JULLIEN

Université Claude Bernard Lyon-I, Hospices Civils de Lyon
Verified email at chu-lyon.fr
Cited by 12251

Prevalence of psoriatic arthritis in patients with psoriasis: a systematic review and meta-analysis of observational and clinical studies

…, DD Gladman, LC Coates, D Jullien… - Journal of the American …, 2019 - Elsevier
Background Wide-ranging prevalence estimates of psoriatic arthritis (PsA) in patients with
psoriasis have been reported. Objectives To assess the prevalence and incidence of PsA in …

Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review

…, L Misery, B Cribier, D Jullien… - Journal of the …, 2013 - Wiley Online Library
Previous epidemiological studies have demonstrated a high prevalence of cardiovascular (
CV ) risk factors in psoriasis patients, including metabolic syndrome, cigarette smoking, …

Carcinogenic risks of psoralen UV‐A therapy and narrowband UV‐B therapy in chronic plaque psoriasis: a systematic literature review

…, H Bachelez, B Cribier, P Joly, D Jullien… - Journal of the …, 2012 - Wiley Online Library
Background Oral 8‐methoxypsoralen–UV‐A (PUVA) and narrowband UV‐B (NB‐UVB or
UVB TL‐01) are effective and widely used treatments for chronic plaque psoriasis. Although …

Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis.

…, LL Demer, SC Castle, D Jullien… - The Journal of …, 1996 - Am Soc Clin Investig
T cell cytokines are known to play a major role in determining protection and pathology in
infectious disease. It has recently become clear that IL-12 is a key inducer of the type 1 T cell …

First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group …

…, M d'Incan, C Bedane, N Bénéton, D Jullien… - The Lancet, 2017 - thelancet.com
Background High doses of corticosteroids are considered the standard treatment for
pemphigus. Because long-term corticosteroid treatment can cause severe and even life-threatening …

What are the best outcome measures for assessing plaque psoriasis severity? A systematic review of the literature

…, M Bagot, B Cribier, P Joly, D Jullien… - Journal of the …, 2010 - Wiley Online Library
Background A wide variety of scoring systems have been proposed to assess severity of
psoriasis. Given its importance as a health issue both for patients and health care systems, it is …

Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based study

…, L Naldi, J Lambert, P Spuls, D Jullien… - Journal of allergy and …, 2021 - Elsevier
Background The multimorbid burden and use of systemic immunosuppressants in people
with psoriasis may confer greater risk of adverse outcomes of coronavirus disease 2019 (…

Association between tumor necrosis factor inhibitors and the risk of hospitalization or death among patients with immune-mediated inflammatory disease and COVID …

…, JM Gelfand, P Gisondi, L Iversen, D Jullien… - JAMA network …, 2021 - jamanetwork.com
Importance Although tumor necrosis factor (TNF) inhibitors are widely prescribed globally
because of their ability to ameliorate shared immune pathways across immune-mediated …

Temperature dependence of dielectric losses in chalcogenide glasses

JC Giuntini, JV Zanchetta, D Jullien, R Eholie… - Journal of Non …, 1981 - Elsevier
The frequency (2 × 10 4 −2 × 10 7 Hz) and temperature (250–600 K) dependence of the
imaginary part of the permittivity, ϵ′', of As 2 Se 3 and Tl 2 SnSe 8.61 is explained within a …

Risk of cancer in psoriasis: a systematic review and meta‐analysis of epidemiological studies

…, F Aubin, B Cribier, P Joly, D Jullien… - Journal of the …, 2013 - Wiley Online Library
The relationship between psoriasis and increased cancer risk is debated. The aim of this
study was to evaluate if there is an increase in the background risk of cancer in psoriasis …